0001104659-24-072880.txt : 20240618 0001104659-24-072880.hdr.sgml : 20240618 20240618170033 ACCESSION NUMBER: 0001104659-24-072880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36598 FILM NUMBER: 241052763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (608) 441-8120 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 4 1 tm2417520-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-14 0 0001279704 Cellectar Biosciences, Inc. CLRB 0001129890 DRISCOLL FREDERICK W C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 1 0 0 0 0 Stock option (right to buy) 2.58 2024-06-14 4 A 0 60000 0 A 2033-12-22 Common Stock 60000 60000 D This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. /s/ Christina Blakley, attorney-in-fact for Frederick Driscoll 2024-06-18